Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defibrotide Therapy for SARS-CoV-2 ARDS.
Frame D, Scappaticci GB, Braun TM, Maliarik M, Sisson TH, Pipe SW, Lawrence DA, Richardson PG, Holinstat M, Hyzy RC, Kaul DR, Gregg KS, Lama VN, Yanik GA. Frame D, et al. Chest. 2022 Aug;162(2):346-355. doi: 10.1016/j.chest.2022.03.046. Epub 2022 Apr 9. Chest. 2022. PMID: 35413279 Free PMC article. Clinical Trial.
Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.
Frame DG, Geer M, Kasha S, Markstrom D, Scappaticci G, Feeney T, Hayduk A, Mansoor HM, Oberfeld A, D'Antonio H, Anand S, Choi SW, Maciejewski J, Pawarode A, Riwes MM, Tewari M, Magenau J, Ghosh M. Frame DG, et al. Front Immunol. 2024 Jun 14;15:1403145. doi: 10.3389/fimmu.2024.1403145. eCollection 2024. Front Immunol. 2024. PMID: 38947326 Free PMC article.
Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, Zhou N, Petty LA, Baang JH, Dillman NO, Frame D, Gregg KS, Kaul DR, Nagel J, Patel TS, Zhou S, Lauring AS, Hanauer DA, Martin E, Sharma P, Fung CM, Pogue JM. Somers EC, et al. Among authors: frame d. medRxiv [Preprint]. 2020 Jun 3:2020.05.29.20117358. doi: 10.1101/2020.05.29.20117358. medRxiv. 2020. Update in: Clin Infect Dis. 2021 Jul 15;73(2):e445-e454. doi: 10.1093/cid/ciaa954 PMID: 32577684 Free PMC article. Updated. Preprint.
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.
Chang L, Frame D, Braun T, Gatza E, Hanauer DA, Zhao S, Magenau JM, Schultz K, Tokala H, Ferrara JL, Levine JE, Reddy P, Paczesny S, Choi SW. Chang L, et al. Among authors: frame d. Biol Blood Marrow Transplant. 2014 Sep;20(9):1407-17. doi: 10.1016/j.bbmt.2014.05.022. Epub 2014 Jun 2. Biol Blood Marrow Transplant. 2014. PMID: 24892262 Free PMC article.
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.
Magenau JM, Braun T, Reddy P, Parkin B, Pawarode A, Mineishi S, Choi S, Levine J, Li Y, Yanik G, Kitko C, Churay T, Frame D, Riwes MM, Harris A, Bixby D, Couriel DR, Goldstein SC. Magenau JM, et al. Among authors: frame d. Ann Hematol. 2015 Jun;94(6):1033-41. doi: 10.1007/s00277-015-2349-4. Epub 2015 Mar 19. Ann Hematol. 2015. PMID: 25784222
111 results